Lemaitre Vascular (LMAT) Tops Q4 EPS by 2c, Offers Guidance

Lemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.38, $0.02 better than the analyst estimate of $0.36. Revenue for the quarter came in at $49 million versus the consensus estimate of $49.01 million.

GUIDANCE:

Lemaitre Vascular sees Q1 2024 EPS of $0.36-$0.41, versus the consensus of $0.34. Lemaitre Vascular sees Q1 2024 revenue of $50.5-52.9 million, versus the consensus of $50.2 million.

Lemaitre Vascular sees FY2024 EPS of $1.60-$1.71, versus the consensus of $1.53. Lemaitre Vascular sees FY2024 revenue of $209.7-214.3 million, versus the consensus of $210 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
• Ulta Beauty (ULTA) Tops Q2 EPS by 38c, Offers Outlook
• The Gap, Inc. (GAP) Tops Q2 EPS by 3c